Cambridge, United Kingdom

Emma Suzanne Cohen

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Emma Suzanne Cohen

Introduction

Emma Suzanne Cohen is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic formulations. With a total of 8 patents to her name, her work has had a substantial impact on the treatment of various medical conditions.

Latest Patents

Among her latest patents is a groundbreaking technology related to dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies. This innovation focuses on methods of treating asthma using these dry powder formulations, which are designed for pulmonary delivery. The technology aims to improve the efficacy of asthma treatments by utilizing specific antibodies that target TSLP.

Career Highlights

Emma has worked with notable companies in the industry, including Medimmune Limited and Zenyth Operations Pty. Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to important advancements in medical science.

Collaborations

Emma has collaborated with esteemed colleagues such as Matthew Alexander Sleeman and Ralph Raymond Minter. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Emma Suzanne Cohen's contributions to the field of biomedical research are noteworthy and impactful. Her innovative patents and collaborations highlight her dedication to improving healthcare solutions. Through her work, she continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…